Morgan Stanley’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-125,832
Closed -$580K 6884
2019
Q1
$580K Buy
125,832
+68,188
+118% +$314K ﹤0.01% 4463
2018
Q4
$202K Sell
57,644
-10,600
-16% -$37.1K ﹤0.01% 5283
2018
Q3
$688K Sell
68,244
-14,752
-18% -$149K ﹤0.01% 4795
2018
Q2
$601K Buy
82,996
+7,590
+10% +$55K ﹤0.01% 4971
2018
Q1
$455K Sell
75,406
-16,844
-18% -$102K ﹤0.01% 5059
2017
Q4
$888K Sell
92,250
-88,657
-49% -$853K ﹤0.01% 4618
2017
Q3
$1.61M Buy
180,907
+44,115
+32% +$392K ﹤0.01% 4072
2017
Q2
$1.73M Buy
136,792
+2,416
+2% +$30.6K ﹤0.01% 3930
2017
Q1
$1.41M Sell
134,376
-8,598
-6% -$90.3K ﹤0.01% 4114
2016
Q4
$1.32M Sell
142,974
-13,918
-9% -$128K ﹤0.01% 4257
2016
Q3
$1.85M Buy
156,892
+36,156
+30% +$426K ﹤0.01% 3555
2016
Q2
$1.56M Sell
120,736
-64,592
-35% -$836K ﹤0.01% 3628
2016
Q1
$2.96M Buy
185,328
+41,942
+29% +$670K ﹤0.01% 3001
2015
Q4
$4.11M Sell
143,386
-40,395
-22% -$1.16M ﹤0.01% 2865
2015
Q3
$5.23M Buy
183,781
+128,871
+235% +$3.67M ﹤0.01% 2621
2015
Q2
$1.97M Sell
54,910
-106,138
-66% -$3.81M ﹤0.01% 3637
2015
Q1
$4.68M Sell
161,048
-392,100
-71% -$11.4M ﹤0.01% 2817
2014
Q4
$11.7M Buy
553,148
+458,228
+483% +$9.66M ﹤0.01% 1917
2014
Q3
$1.84M Sell
94,920
-224,000
-70% -$4.34M ﹤0.01% 3513
2014
Q2
$4.98M Sell
318,920
-96,124
-23% -$1.5M ﹤0.01% 2672
2014
Q1
$8.6M Sell
415,044
-193,380
-32% -$4.01M ﹤0.01% 2076
2013
Q4
$7.85M Buy
608,424
+170,811
+39% +$2.2M ﹤0.01% 2146
2013
Q3
$5.1M Buy
437,613
+389,436
+808% +$4.54M ﹤0.01% 2405
2013
Q2
$222K Buy
+48,177
New +$222K ﹤0.01% 4784